Price $11.43 |
Market Cap
1.81B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
20.4
|
P/B
3.17
|
P/S
3.98
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
14.2
|
Op. Cash Flow
152.2K
|
FCF
1.0
|
|
Op. Margin
19.80%
|
Net Margin
24.00%
|
ROE
19.90%
|
ROI
35.20%
|
|
ROA
11.30%
|
EPS Growth
-52.40%
|
Current Ratio
6.1
|
Debt/Equity
38.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CordovaCann Corp (LVRLF) | $0.09 | - | - | 12.6M | Strong Buy |
| InMed Pharmaceuticals Inc (INM) | $0.30 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.04 | - | - | 5M | Strong Buy |
| Rigel Pharmaceuticals Inc (RIGL) | $1.11 | - | - | 139.2M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
